U.S. Digital Therapeutics Market Projection : a CAGR of 19.2% from 2020 to 2027 ; 2MORROW, and Fitbit are Key Players in the Market

Allied Market Research published a report, titled, "U.S. Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product (Software and Device), and Sales Channel (Business-to-Business(B2B), Business-to-Consumer (B2C)): Opportunity Analysis and Industry Forecast, 2020-2027." According to the report, the U.S. digital therapeutics industry generated $1.16 billion in 2019, and is estimated to generate $5.08 billion by 2027, growing at a CAGR of 19.2% from 2020 to 2027.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 https://www.alliedmarketresearch.com/request-sample/A06701

The growth of the U.S. digital therapeutics market is propelled by the increasing adoption of tablets, smartphones, and smart wearables, coupled with the utilization of healthcare apps. There's also a surge in the demand to mitigate healthcare costs and the adoption of technologically advanced healthcare products and applications. However, market growth is hindered by concerns regarding data privacy and the absence of adequate reimbursement policies. Conversely, the presence of supportive laws and regulations for digital health technologies, along with a rise in investments from market players, present new opportunities in the foreseeable future.

𝑻𝒉𝒆 𝒅𝒊𝒂𝒃𝒆𝒕𝒆𝒔 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒎𝒂𝒊𝒏𝒕𝒂𝒊𝒏 𝒊𝒕𝒔 𝒅𝒐𝒎𝒊𝒏𝒂𝒏𝒕 𝒑𝒐𝒔𝒊𝒕𝒊𝒐𝒏 𝒕𝒉𝒓𝒐𝒖𝒈𝒉𝒐𝒖𝒕 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅
In 2019, the diabetes segment led the U.S. digital therapeutics market, holding over one-fourth of the market share, and is projected to sustain its predominant position in the forecast period. This is credited to the widespread prevalence of diabetes and the availability of cost-effective treatment solutions. Conversely, the obesity segment is anticipated to experience the most rapid compound annual growth rate (CAGR) of 22.1% from 2020 to 2027, driven by the increasing number of overweight individuals and the easy accessibility of digital therapeutics software applications designed to assist patients in maintaining proper diets and tracking physical activities.

𝐓𝐡𝐞 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐜𝐞 𝐛𝐲 2027
In 2019, the software segment captured over two-thirds of the U.S. digital therapeutics market and is projected to retain its revenue dominance through 2027. Additionally, this segment is expected to exhibit the highest compound annual growth rate (CAGR) of 20.3% during the forecast period. This growth is driven by a rising demand to reduce healthcare expenses and the presence of innovative software and applications with advanced features that aid individuals in maintaining their health and accessing appropriate treatments. The research also evaluates the devices segment.

𝑭𝒐𝒓 𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆 𝑬𝒏𝒒𝒖𝒊𝒓𝒚 𝒂𝒕: https://www.alliedmarketresearch.com/purchase-enquiry/7066

𝑻𝒉𝒆 𝒃𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝒕𝒐 𝒃𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒄𝒐𝒏𝒕𝒊𝒏𝒖𝒆 𝒊𝒕𝒔 𝒉𝒊𝒈𝒉𝒆𝒔𝒕 𝒄𝒐𝒏𝒕𝒓𝒊𝒃𝒖𝒕𝒊𝒐𝒏 𝒃𝒚 2027
In 2019, the business-to-business segment accounted for nearly two-thirds of the U.S. digital therapeutics market, and it is expected to maintain its leading position throughout the forecast period. This dominance is attributed to the increasing number of industry players offering favorable reimbursement policies to employees through their employers in the U.S. However, the business-to-consumers segment is projected to witness the highest compound annual growth rate (CAGR) of 19.8% from 2020 to 2027. This growth is driven by the easy accessibility and availability of software and smart devices, as well as the growing demand for digital therapeutic products among patients and caregivers.

𝑳𝒆𝒂𝒅𝒊𝒏𝒈 𝒎𝒂𝒓𝒌𝒆𝒕 𝒑𝒍𝒂𝒚𝒆𝒓𝒔
2MORROW, Inc.
Fitbit, Inc. (Twine Health, Inc.)
Livongo Health, Inc.
Medtronic Plc.
Omada Health, Inc.
Pear Therapeutics, Inc.
Proteus Digital Health, Inc.
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Welldoc, Inc.

𝑶𝒖𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑺𝒐𝒍𝒖𝒕𝒊𝒐𝒏 𝑷𝒓𝒐𝒗𝒊𝒅𝒆𝒔 𝒀𝒐𝒖 𝑨𝒏𝒔𝒘𝒆𝒓 𝒕𝒐 𝑩𝒆𝒍𝒐𝒘 𝑴𝒆𝒏𝒕𝒊𝒐𝒏𝒆𝒅 𝑸𝒖𝒆𝒔𝒕𝒊𝒐𝒏:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2027?
Which region has more opportunities?

𝑲𝒏𝒐𝒘 𝑴𝒐𝒓𝒆- https://www.alliedmarketresearch.com/us-digital-therapeutics-market-A06701

𝑶𝒕𝒉𝒆𝒓 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑫𝒐𝒎𝒂𝒊𝒏
𝑭𝒂𝒕𝒕𝒚 𝑩𝒂𝒔𝒆𝒔 𝑭𝒐𝒓 𝑺𝒖𝒑𝒑𝒐𝒔𝒊𝒕𝒐𝒓𝒊𝒆𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/fatty-bases-for-suppositories-market-A31722

𝑬𝒙𝒕𝒆𝒓𝒏𝒂𝒍 𝑼𝒓𝒊𝒏𝒆 𝑴𝒂𝒏𝒂𝒈𝒆𝒎𝒆𝒏𝒕 𝑷𝒓𝒐𝒅𝒖𝒄𝒕𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/external-urine-management-products-market-A31363

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.